Qube Research & Technologies Ltd
All 13F Filings
- Location
- London, X0
- Most recent 13F
- Q4 2025
- Holdings value ($000)
- 98,444,689
- Description
- London London based model driven portfolio platform with a regulated corporate organization and a pragmatic and allocation disciplined investment mandate. The approach emphasizes fundamental research depth, concentrated position governance, and multi sleeve portfolio balancing for systematic institutional portfolios. Portfolio governance emphasizes clear accountability, measured exposure, and resilient implementation through risk adjusted decision framing and mandate calibration.
- Website
- https://www.qube-rt.com/
- Founded
- —
- Chairman
- —
- CEO
- —
- All SEC filings
- View on sec.gov
Sector allocation over time (stocks only)
Stacked by quarter. Hover to see detailed sector breakdown for any quarter.
| Quarter | Date Filed | Holdings | Value ($000) | Form Type | Name |
|---|---|---|---|---|---|
| Q4 2025 | 2/17/2026 | 3,633 | 98,444,689 | 13F-HR | Qube Research & Technologies Ltd |
| Q3 2025 | 11/14/2025 | 3,527 | 96,783,126 | 13F-HR | Qube Research & Technologies Ltd |
| Q2 2025 | 8/14/2025 | 3,505 | 98,415,070 | 13F-HR | Qube Research & Technologies Ltd |
| Q1 2025 | 5/15/2025 | 3,445 | 86,210,652 | 13F-HR | Qube Research & Technologies Ltd |
| Q4 2024 | 2/14/2025 | 3,415 | 76,267,153 | 13F-HR | Qube Research & Technologies Ltd |
| Q3 2024 | 11/14/2024 | 3,210 | 67,845,624 | 13F-HR | Qube Research & Technologies Ltd |
| Q2 2024 | 8/14/2024 | 3,732 | 63,268,663 | 13F-HR | Qube Research & Technologies Ltd |
| Q1 2024 | 5/14/2024 | 4,406 | 63,076,372 | 13F-HR | Qube Research & Technologies Ltd |
| Q4 2023 | 2/13/2024 | 4,300 | 51,374,068 | 13F-HR | Qube Research & Technologies Ltd |
| Q3 2023 | 11/13/2023 | 4,065 | 38,274,754 | 13F-HR | Qube Research & Technologies Ltd |
| Q2 2023 | 8/14/2023 | 2,333 | 27,504,969 | 13F-HR | Qube Research & Technologies Ltd |
| Q1 2023 | 5/15/2023 | 2,482 | 23,249,082 | 13F-HR | Qube Research & Technologies Ltd |
| Q4 2022 | 2/14/2023 | 2,402 | 18,681,389 | 13F-HR | Qube Research & Technologies Ltd |
| Q3 2022 | 11/14/2022 | 2,457 | 16,793,106 | 13F-HR | Qube Research & Technologies Ltd |
| Q2 2022 | 8/15/2022 | 2,434 | 13,557,495 | 13F-HR | Qube Research & Technologies Ltd |
| Q1 2022 | 5/9/2022 | 2,387 | 11,802,218 | 13F-HR | Qube Research & Technologies Ltd |
| Q4 2021 | 2/10/2022 | 2,473 | 12,956,831 | 13F-HR/A - RESTATEMENT | Qube Research & Technologies Ltd |
| Q4 2021 | 2/1/2022 | 2,466 | 12,940,656 | 13F-HR | Qube Research & Technologies Ltd |
| Q3 2021 | 11/12/2021 | 2,127 | 7,972,455 | 13F-HR | Qube Research & Technologies Ltd |
| Q2 2021 | 8/13/2021 | 2,203 | 8,775,716 | 13F-HR | Qube Research & Technologies Ltd |
| Q1 2021 | 5/14/2021 | 1,859 | 6,305,978 | 13F-HR | Qube Research & Technologies Ltd |
| Q4 2020 | 2/16/2021 | 1,754 | 7,033,525 | 13F-HR | Qube Research & Technologies Ltd |
| Q3 2020 | 11/12/2020 | 1,612 | 7,007,129 | 13F-HR | Qube Research & Technologies Ltd |
| Q2 2020 | 8/14/2020 | 1,679 | 6,815,434 | 13F-HR | Qube Research & Technologies Ltd |
| Q1 2020 | 5/15/2020 | 1,067 | 2,434,622 | 13F-HR | Qube Research & Technologies Ltd |
| Q4 2019 | 2/13/2020 | 1,508 | 3,186,249 | 13F-HR | Qube Research & Technologies Ltd |
Swipe for more columns
Money flow by instrument (QoQ, ex-options)
Derivatives reported exposure ($000):
28.63 M
(29.1% of total reported value)
· QoQ Δ:
+2.505 M
| Type | Value ($000) | Share % | Inflow | Outflow | Net |
|---|---|---|---|---|---|
| Stocks | 69.08 M | 99.0% | 0 | 833.6 K | -833.6 K |
| ETFs | 549.8 K | 0.8% | 0 | 88.7 K | -88.7 K |
| Debt | 146 | 0.0% | 0 | 179 | -179 |
| Other | 170.2 K | 0.2% | 80.04 K | 0 | 80.04 K |
Swipe for more columns
Fund Snapshot
Q4 2025
Latest filed
2/17/2026
Total value ($000)
98,444,689
Holdings
3633
QoQ value change ($000)
1,661,563
(1.7%)
Value = total reported 13F value ($000), Holdings = number of positions.
13F Value over time
Holdings count over time
Sector allocation (latest, stocks only)
Methodology:
sector allocation is stocks-only;
instrument flow table is ex-options;
options exposure is shown separately.
Details.